Navigation Links
LOTUS™ Electronic Oxygen Conserver (with alarm)

ProductsLOTUS™ Electronic Oxygen Conserver (with alarm)
Company CHAD Therapeutics, Inc.
Item LOTUS™ Electronic Oxygen Conserver (with alarm)
Features 
  • Contains a breath sensor alarm for overnight use.
  • Provides every-breath delivery with a built-in regulator.
  • Offers a 5:1 increase in usage time! This means that an oxygen cylinder used in conjunction with a LOTUS conserver will last five times longer than a cylinder without a conserving device.
  • Offers 1-6 lpm flow equivalency settings, including 1.5 and 2.5.
  • Delivers fixed pulses of oxygen within the first 200 milliseconds of inspiration.
  • Sleek, lightweight design - only 14.5 oz.
  • Simple patient operation. One control knob does it all!
  • Equipped with an audible and visual low battery alarm.
  • Extended battery life - up to four months at eight hours per day use.
  • Uses two AA-size alkaline batteries.
  • Optional rechargeable battery pack and charger allows the patient to recharge the battery even while in use.
  • Reliability backed by a 2-year warranty.
  • Description Redesigning the World's Oxygen Therapy One Device at a Time.

    Everything you like about our OXYMATIC 400 Series conservers, only better!
    Info CHAD Therapeutics, Inc.
    Customer Service: (800) 423-8870
    Web site: http://www.chadtherapeutics.com

    Related medicine products :

    1. LOTUS™ Electronic Oxygen Conserver (without alarm)
    2. MaximEyes Practice Management and Electronic Medical Records Software Solutions
    3. PRAXIS® Electronic Medical Records v. 2.19
    4. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
    5. ExamWRITER Electronic Medical Records
    6. NextGen Electronic Medical Records module
    7. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
    8. Cardiology Software for Electronic Medical Records
    9. HealthMatics EMR Electronic Medical Record
    10. Littmann Electronic Stethoscope Model 2000
    11. 3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction
    Teardrop punch, Left
    Meniscus Screw
    Biosteon™ (HA/PLLA) Wedge Interference Screws
    Graft Workstation
    Medicine Products:
    (Date:12/5/2009)... , NEW ORLEANS, Dec. 5 Leukemia and myelopr... blood cancers. Research presented today at the 51...ology introduces potential new treatment options a...ing from acute promyelocytic leukemia, chronic mye..., and myelofibrosis that are based on a better und...
    (Date:12/5/2009)... The MAMA campaign is a col...ertified Professional Midwives (NACPM), Midwives A...ifery (CfM), International Center for Traditional ...dwives (NARM), and the Midwifery Education Accredi...efforts of The MAMA Campaign to secure federal rec...
    (Date:12/4/2009)... , SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won...sary in the SF Bay Area by popular vote conducted ... only three months in operation, the SF Bay commun...tion for accessing medicinal marijuana. ,, The r...e obvious: a dispensary which caters to the consum...
    (Date:12/4/2009)... , MADISON HEIGHTS, Mich., Dec. 4 The E...of BetterInvesting Magazine today announced All...Stock to Study" and C.R. Bard, Inc. (NYSE: BCR...vestors, informational and educational use. ,, "Th...tunities involving its flagship drug Botox and oth...
    (Date:12/4/2009)... , STANFORD, Calif. A new study shows that muscl...s ability to squeeze shut properly. The work, perf...t patients with conditions such as gastric reflux ...sed to strengthen sphincters, which are the bands ... intestinal tract. Weakness in these areas can cau...
    Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
    ...ould use,a little pampering now and then. Think yo... survivorship? Let the Pennsylvania Breast Cancer ...e of everything!, All you have to do is tell us i... for a real treat! Salon Art,Tiff, located on the ...
    ...lps Answer That Question, BREA, Calif., March 5 ...health insurance Web site in the United States, no...r intellectually challenged,their dogs are with a ... dog,s brain power. VPI,s Canine Aptitude Test,is ...
    ... expert says , , WEDNESDAY, March 5 (Healt... a person,s sensitivity to warfarin are important ...ing drug, researchers report. , That information a...tic test when first prescribing warfarin, better k...
    ...ccess to necessary medications for ...rch 5 Today Eli Lilly and,Company (NYSE: LLY ) r...ity,-- the principle that insurers should treat me...eks to pay for the bill:,by increasing the so-call...
    ... leading global,provider of clinical documentation...for the release of its financial results for the f...lans to issue its earnings release for the fourth ....m. CT.,The number to call for this interactive te...
    ...d revenues of $82.9 million, up 18% from the prior...er, - Earnings per share of $0.26, an increase of ... year,s first quarter - Operati...fe,sDHA(TM), COLUMBIA, Md., March 5 Martek Biosc...
    Other Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter 'Makeover for Mom' Contest 2Health News:Is Your Dog a Canine-stein or a Bonehead? 2Health News:Is Your Dog a Canine-stein or a Bonehead? 3Health News:Genetic Test Predicts Response to Warfarin 2Health News:Genetic Test Predicts Response to Warfarin 3Health News:Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says 2Health News:Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says 3Health News:Martek Announces First Quarter 2008 Financial Results 2Health News:Martek Announces First Quarter 2008 Financial Results 3Health News:Martek Announces First Quarter 2008 Financial Results 4Health News:Martek Announces First Quarter 2008 Financial Results 5Health News:Martek Announces First Quarter 2008 Financial Results 6Health News:Martek Announces First Quarter 2008 Financial Results 7Health News:Martek Announces First Quarter 2008 Financial Results 8Health News:Martek Announces First Quarter 2008 Financial Results 9Health News:Martek Announces First Quarter 2008 Financial Results 10Health News:Martek Announces First Quarter 2008 Financial Results 11
    (Date:12/3/2009)...WARRENDALE, Pa., Dec. 3 Radiology imaging leader ...ntegration capabilities at the November 2009 Radio...nnect.PACS(TM) product, enabling the first radiol...atest release in the company,s newly branded Cert...p://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
    (Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, D...iR-122, a microRNA Important for,Hepatitis C Viral...itis C,Virus in the Bloodstream in Chimpanzees Chr... - SPC3649 Demonstrates Efficacy With No Evidence ...in the Treated Animals - Signaling a Potential,Ben...
    (Date:12/3/2009)....C., Dec. 3 In response to the increasingly criti... the evolving healthcare delivery system, Duke Med...matics (DCHI) to provide a campus focus for health...rdisciplinary approach to education that will prod...lthcare administrators with an expertise in the us...
    Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 1With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 1Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 2Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 4